C Wei, I L Andrulis
Index: Somat. Cell Mol. Genet. 19(4) , 321-30, (1993)
Full Text: HTML
Gene amplification is commonly observed in primary tumors and established drug-resistant cell lines, both of which are generally aneuploid. However, this process is undetectable (frequency < 10(-9) in normal diploid mammalian cell lines. To investigate whether gene amplification can occur in pluripotent diploid cells, we have selected drug-resistant mutants of mouse embryonic stem (ES) cells. We had previously found that Chinese hamster ovary (CHO) and human cell lines selected in albizziin (Alb), an amino acid analog of L-glutamine, overexpress asparagine synthetase (AS) due to gene amplification. The same drug selection system was applied to ES cells to isolate single-step and multistep drug-resistant mutants. Albizziin-resistant ES cells exhibited elevated levels of AS; however, drug resistance in ES cells was associated with mRNA overexpression without gene amplification. AS gene amplification was observed in only one drug-resistant cell line and was preceded by AS mRNA overexpression. Gene amplification in the latter coincided with the loss of the pluripotent nature of the ES cells.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
L-Albizziin
CAS:1483-07-4 |
C4H9N3O3 |
Molecular and genetic characterization of human cell lines r...
1990-01-01 [Somat. Cell Mol. Genet. 16(1) , 59-65, (1990)] |
Chromosomal alterations associated with overproduction of as...
1983-03-01 [Mol. Cell. Biol. 3(3) , 391-8, (1983)] |
Use of the Escherichia coli gene for asparagine synthetase a...
1987-05-01 [Mol. Cell. Biol. 7(5) , 1623-8, (1987)] |
Characterization of single step albizziin-resistant Chinese ...
1985-06-25 [J. Biol. Chem. 260(12) , 7523-7, (1985)] |
Effects of intermediary metabolites and electron transport i...
1989-12-01 [Biochem. Pharmacol. 38(23) , 4327-32, (1989)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved